Lombard Odier Asset Management (Switzerland)’s Twist Bioscience TWST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-188,781
Closed -$2.85M 369
2023
Q1
$2.85M Buy
188,781
+63,761
+51% +$1.41M 0.25% 98
2022
Q4
$2.98M Sell
125,020
-26,237
-17% -$761K 0.24% 95
2022
Q3
$5.33M Sell
151,257
-11,039
-7% -$469K 0.45% 55
2022
Q2
$5.67M Sell
162,296
-52,405
-24% -$1.86M 0.48% 53
2022
Q1
$10.6M Buy
214,701
+14,543
+7% +$806K 0.83% 45
2021
Q4
$15.5M Sell
200,158
-16,726
-8% -$1.72M 0.99% 38
2021
Q3
$23.2M Buy
216,884
+20,208
+10% +$2.31M 1.44% 30
2021
Q2
$26.2M Buy
196,676
+89,273
+83% +$10.4M 1.33% 22
2021
Q1
$13.3M Buy
+107,403
New +$16.3M 0.88% 45

Other funds holding TWST

Lombard Odier Asset Management (Switzerland)'s TWST Position: Q2 2023 in Review

Lombard Odier Asset Management (Switzerland) sold out of Twist Bioscience (TWST) in Q2 2023, closing a stake of 188,781 shares — an estimated $2.85M sold.

Lombard Odier Asset Management (Switzerland) first reported a position in TWST in Q1 2021 and held it in 9 quarters. The position peaked at $26.2M in Q2 2021. 194 funds tracked by Wall St. Rank hold TWST as of Q2 2023.

  • Lombard Odier Asset Management (Switzerland) reported no remaining Twist Bioscience position as of Q2 2023 after selling out during the quarter.
  • Lombard Odier Asset Management (Switzerland) sold 188,781 Twist Bioscience shares in Q2 2023, an estimated $2.85M.
  • Lombard Odier Asset Management (Switzerland) first reported a position in Twist Bioscience in Q1 2021 and held it in 9 quarters.
  • Lombard Odier Asset Management (Switzerland)'s Twist Bioscience position peaked at $26.2M in Q2 2021.
  • 194 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2023.

Based on Lombard Odier Asset Management (Switzerland)'s 13F filing for Q2 2023, filed 14 Aug 2023.